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ABSTRACT
Rationale HIV-infected adults are at an increased risk of
lower respiratory tract infections. HIV infection impairs
systemic acquired immunity, but there is limited
information in humans on HIV-related cell-mediated
immune defects in the lung.
Objective To investigate antigen-specific CD4+ T cell
responses to influenza virus, Streptococcus pneumoniae
and Mycobacterium tuberculosis antigens in
bronchoalveolar lavage (BAL) and peripheral blood
between HIV-infected individuals and HIV-uninfected
Malawian adults.
Methods We obtained BAL fluid and blood from
HIV-infected individuals (n¼21) and HIV-uninfected
adults (n¼24). We determined the proportion of T cell
subsets including naive, memory and regulatory T cells
using flow cytometry, and used intracellular cytokine
staining to identify CD4+ T cells recognising influenza
virus-, S pneumoniae- and M tuberculosis-antigens.
Main results CD4+ T cells in BAL were predominantly
of effector memory phenotype compared to blood,
irrespective of HIV status (p<0.001). There was immune
compartmentalisation with a higher frequency of antigen-
specific CD4+ T cells against influenza virus,
S pneumoniae and M tuberculosis retained in BAL
compared to blood in HIV-uninfected adults (p<0.001 in
each case). Influenza virus- and M tuberculosis-specific
CD4+ T cell responses in BAL were impaired in
HIV-infected individuals: proportions of total
antigen-specific CD4+ T cells and of polyfunctional IFN-g
and TNF-a-secreting cells were lower in HIV-infected
individuals than in HIV-uninfected adults (p<0.05 in each
case).
Conclusions BAL antigen-specific CD4+ T cell
responses against important viral and bacterial
respiratory pathogens are impaired in HIV-infected
adults. This might contribute to the susceptibility of
HIV-infected adults to lower respiratory tract infections
such as pneumonia and tuberculosis.
INTRODUCTION
Respiratory infections are a leading cause of death
in lower income countries, accounting for approx-
imately three million deaths a year.1 Infants, the
elderly and immunocompromised individuals are
particularly susceptible to these infections. In
particular, HIV-infected individuals are 30 times
more likely than uninfected adults to suffer from
bacterial pneumonia or active tuberculosis.2 3
Southern Africa is the region with the world’s
highest burden of HIV infection, with over nine
countries, including Malawi, having an estimated
HIV prevalence that is greater than 10%.4
Defence against respiratory infection involves
mucosal and systemic immunity.5 Antigen-speciﬁc
CD4+ Tcells are important as they protect against
respiratory infections.6e8 Cytokines secreted by
CD4+ Tcells, such as IFN-g, TNF-a, IL-2, IL-17 and
IL-22,9e12 are critical to the activation of macro-
phages9 and the recruitment of neutrophils,10 and
enhance the magnitude and quality of CD8+ Tcell
responses.12 Immune protection against common
viral and bacterial respiratory pathogens depends
on the integrity of these effector responses. There is
limited information about the phenotype and
function of these CD4+ T cells within the human
lung.
Studies of the human lung suggest that mecha-
nisms of local intrapulmonary immunity may differ
from those mediating systemic immunity. Inﬂu-
enza virus antigen-speciﬁc memory CD4+ T cells
from lung tissue were present at higher frequencies
and produced more IFN-g than those from periph-
eral blood in patients undergoing lobectomy for
a localised solitary peripheral lung carcinoma who
had no symptoms of upper respiratory infection.13
In patients with tuberculosis, IFN-g and TNF-
a responses to Puriﬁed Protein Derivative (PPD)
were stronger by CD4+ Tcells from BAL ﬂuid than
by CD4+ T cells from peripheral blood.14
The decline in immunity caused by HIV is not
equally distributed among immunological sites. In
particular, the depletion of CD4+ T cells primarily
occurs at sites of ‘persistent inﬂammation’ such as
the mucosa, which may leave individuals vulner-
able to acute infections. Brenchley et al showed
that there was a rapid depletion of mucosal gut T
cells during early HIV infection while pulmonary
CD4+ T cell depletion was less acute.15 Clinical
evidence indicates that there is a high burden of
pneumococcal pneumonia and tuberculosis early on
in HIV infection when peripheral CD4+ T cell
counts are relatively stable.16 17 We hypothesised
that HIV infection preferentially depletes antigen-
speciﬁc T cells against common respiratory patho-
gens within the lung compartment, which
predisposes individuals to respiratory infections.
The authors have compared baseline T cell
phenotypes and antigen-speciﬁc CD4+ T cells in
BAL and peripheral blood, between HIV-infected
individuals and HIV-uninfected adults. The aim
of the authors was to compare Tcell phenotypes in
BAL and peripheral blood between the two
groups of subjects; to assess antigen-speciﬁc CD4+
T cell responses to common respiratory antigens;
and to investigate whether HIV infection differen-
tially affects the lung and peripheral blood
compartments.
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METHODS
Participants
Adult volunteers with no recent history of severe respiratory
diseases and a normal chest x-ray were recruited by advertise-
ment in the Queen Elizabeth Central Hospital, Blantyre,
Malawi. All participants gave written-informed-consent to HIV
testing, venesection and bronchoscopy. The authors enrolled
HIV-uninfected adults and asymptomatic anti-retroviral therapy
naive HIV-infected individuals (WHO stage 1) into the study.
The exclusion criteria for the study were as follows: the presence
of other immunocompromising illnesses such as diabetes and
cancer, the use of immunosuppressive drugs, cigarette smoking,
moderate or severe anaemia (HB<8 g/dl), and known or possible
pregnancy. This study complies with local institutional guide-
lines and was approved by the College of Medicine Research
Ethics Committee of the University of Malawi (COMREC P.01/
09/717) and the Liverpool School of Tropical Medicine Research
Ethics Committee (LSTM REC 08.61).
Sample collection and processing
Peripheral blood samples were collected on all subjects. Periph-
eral blood mononuclear cells (PBMCs) were isolated from blood
by density centrifugation using Lymphoprep (Axis-shield,
Norway) according to the manufacturer ’s instructions. Bron-
choscopy and BAL collection was carried out as previously
described.18 The BAL samples were ﬁltered and spun to obtain
a cell pellet. The cells were counted and re-suspended in
complete cell culture media (containing RPMI, L-glutamine,
penicillin/streptomycin and HEPES (all from Sigma-Aldrich,
UK) with 2% (vol/vol) heat-inactivated human AB serum
(National Blood Services, Blantyre)).
Phenotyping of T cell subsets
PBMCs and BAL cells were stained with ﬂuorochrome conjugate
antibodies when cell numbers were sufﬁcient. Anti-CD3 ﬂuo-
rescein isothiocyanate (FITC), anti-CD4 Paciﬁc blue, anti-CD8
allophycocyanin-H7 (APC-H7), anti-CD45RA phycoerythrin
(PE), and anti-CCR7 allophycocyanin (APC) (all antibodies from
BD Bioscience, UK) were used to characterise: naive
(CD45RA+CCR7+), central memory (CD45RACCR7+),
effector memory (CD45RACCR7) and terminal effector T
cells (CD45RA+CCR7).19 Anti-CD4 paciﬁc blue, anti-CD25
FITC (all antibodies from BD Bioscience, UK) and anti-FoxP3 PE
(eBioscience, UK) were used to characterise regulatory T cells
(CD4+CD25hiFoxP3+).20 The samples were acquired on CyAn
ADP 9 Colour ﬂow cytometer (Beckman Coulter, USA) and
analysed using FlowJo (TreeStar, USA).
Intracellular cytokine staining
PBMCs and BAL cells re-suspended in complete cell culture
media were cultured in a volume of 200 ml in a 96 well plate and
stimulated with inﬂuenza vaccine (0.45 mg/ml), pneumococcal
cell culture supernatant (8 mg/ml) or Puriﬁed Protein Derivative
(PPD, 10 mg/ml) for 2 h. Brefeldin A (1 ml) (BD Bioscience, UK)
was added at 2 h and the cells were cultured for a further 16 h.
Cells were harvested and stained with Violet Viability dye
(LIVE/DEAD Fixable Dead Cell Stain kit, Invitrogen, UK) as
per manufacturer ’s instructions. Cells were then surface stained
with anti-CD4 FITC and CD8 PerCP (all BD Bioscience, UK).
Next, cells were permeabilised and ﬁxed using Cytoﬁx/Cyto-
perm (BD Bioscience, UK) as per manufacturer ’s instructions.
The cells were then stained with anti-interferon-gamma (IFN-g)
APC and anti-tumour necrosis factor-alpha (TNF-a) Alexa ﬂour
488 antibodies (all BD Bioscience, UK) to detect intracellular
cytokines. Lastly, cells were washed with 1x Perm Wash (BD
Bioscience, UK), re-suspended in FACS ﬂow and acquired on
a ﬂow on CyAn ADP 9 Colour ﬂow cytometer (Beckman
Coulter, USA). Flow cytometry analysis was done using FlowJo
(TreeStar, USA).
Statistical analysis
Statistical analyses and graphical presentation were carried out
using Graphpad Prism 5 (GraphPad Software, USA). Student t
tests were used for the volunteer demographic data with the
exception of gender, where a c2 test was used instead. For the
experimental data, ManneWhitney U test was used for non-
paired data and Wilcoxon sign ranked test for paired data.
Results are given as mean with ranges or medians with IQRs.
Differences were considered statistically signiﬁcant if p values
were less than 0.05.
RESULTS
Demographic characteristics of study population
Basic demographics are shown in table 1. HIV-uninfected
Malawian adults ((n¼24, females 11) mean age 38 years)) and
asymptomatic HIV-infected adults ((n¼21, females 11) mean
age 40 years)) participated in the study. The mean CD4 count
for HIV-infected individuals was 375 cells/ml. All participants
were asymptomatic and had no recent history of respiratory
infection or tuberculosis. The mean BAL cell concentration was
comparable between HIV-infected individuals and HIV-unin-
fected adults (16.23106cells/100 ml vs 20.53106cells/100 ml
respectively; p¼0.1134), but the proportion of lymphocytes in
the BAL cells was higher in HIV-infected individuals than HIV-
uninfected adults (17.8% vs 9.0%; p¼0.0106).
Proportions of naive, memory and regulatory T cells in BAL and
peripheral blood
CD4 and CD8 T cells
There was a lower proportion of CD4+ Tcells in the total CD3+
T cell population in HIV-infected individuals compared to HIV-
uninfected adults in both BAL (median 35.0% vs 65.5%,
p<0.001) and peripheral blood (median 38.5% vs 61.2%,
p<0.001). The proportion of CD8+ T cells in the total CD3+ T
cell population was higher in HIV-infected individuals compared
to HIV-uninfected adults in both BAL (median 59.7% vs 34.5%,
p<0.05) and peripheral blood (median 61.5% vs 38.8%, p<0.05)
(ﬁgure 1A).
Naive and memory T cells
To examine whether the proportion of T cell subsets was similar
between compartments and whether they were altered by
HIV infection, the authors measured expression of CD45RA
Table 1 Characteristics of subjects enrolled in the study
HIV-uninfected
adults n[24
HIV-infected
adults n[21 p Value
Sex: female/male 11/13 11/10 0.6611
Age, mean yr6SD 38617 40618 0.7733
Systemic mean CD4+
cells/ml6SD
7676208 3756172 <0.0001
BAL cells/100ml BALF,
mean6SD
16.2310668.23106 20.5310669.53106 0.1134
BAL lymphocyte %,
mean6SD
9.067.3 17.8614.1 0.0106
WHO Stage NA Stage 1
BAL, bronchoalveolar lavage; BALF, BAL fluid; N/A, not applicable.
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and CCR7 on CD4+ and CD8+ T cellsdas described in the
materials and methods section. BAL CD4+ and CD8+ T cells
were predominantly of effector memory phenotype
(CD4+CD45RACCR7, median 98%; CD8+CD45RACCR7,
median 90%) compared to peripheral blood CD4+ and
CD8+ T cells which were distributed among naive
(CD4+CD45RA+CCR7+, median 25%; CD8+CD45RA+CCR7+,
median 30%), central memory (CD4+CD45RACCR7+, median
37%; CD8+CD45RACCR7+, median 5%), effector memory
(CD4+ CD45RACCR7, median 37%; CD8+ CD45RACCR7,
median 20%) and terminal effector phenotypes
(CD4+CD45RA+CCR7, median 6%; CD8+ CD45RA+CCR7,
median 45%) (ﬁgure 2). In BAL, there was a higher proportion
of effector memory cells in HIV-infected individuals
compared to HIV-uninfected adults (CD4, median 98.9% vs
98.1% p¼0.03; CD8, median 96.3% vs 90.3% p¼0.03) and
a lower proportion of central memory T cells (CD4, median
0.37% vs 1.42% p¼0.003; CD8, median 0.44% vs 1.88%
p¼0.007) (ﬁgure 2A,B). In peripheral blood, there was no
difference in peripheral blood CD4+ T cell subsets between
HIV-infected and HIV-uninfected groups. However, the HIV-
infected group had a higher proportion of CD8+ effector
memory T cells (median 29.6% vs 17.8%, p¼0.007) and
a lower proportion of CD8+ terminal effector T cells (median
22.2% vs 45.0%, p¼0.01) than the HIV-uninfected group
(ﬁgure 2C,D).
Figure 1 Lower proportion of CD4+ T
cells in BAL and peripheral blood of HIV-
infected individuals compared to HIV-
uninfected adults. T lymphocytes
obtained from BAL and peripheral blood
were stained with anti-CD3 FITC, anti-
CD4 Pacific blue and anti-CD8 APC-H7
fluorochrome conjugated antibodies. (A)
The data shows a lower proportion of
CD4+ T cells in BAL and peripheral
blood of HIV-infected individuals
compared to HIV-uninfected adults. (B)
The data shows a higher proportion of
CD8+ T cells in BAL and peripheral
blood of HIV-infected individuals
compared to HIV-uninfected adults.
Significance was assessed using
ManneWhitney U test. Black horizontal
bars represent median and IQRs.
Figure 2 The proportions of naive and
memory T cell subsets are different
between BAL and peripheral blood, and
are altered during HIV infection. T
lymphocytes obtained from BAL and
peripheral blood were stained with anti-
CD3 FITC, anti-CD4 Pacific blue, anti-
CD8 APC-H7, anti-CD45RA PE and anti-
CCR7 APC fluorochrome conjugated
antibodies. The proportion of
naı¨ve (CD45RA+CCR7+), central
memory (CD45RACCR7+), effector
memory (CD45RACCR7) and terminal
effector (CD45RA+CCR7) were
defined. (A, B, C, D) The data shows
that BAL T cells (upper) were
predominantly of effector memory
phenotype compared to peripheral blood
(lower), in which T cells were
distributed among naive, central
memory, effector memory and terminal
effector phenotypes. (A, B) The data
shows a higher proportion of effector
memory and lower proportion of central
memory BAL CD4+ (left) and CD8+
(right) T cells in HIV-infected individuals
compared to HIV-uninfected adults. (C,
D) The data shows no difference in
peripheral blood CD4+ T cell subsets
between HIV-infected individuals
compared to HIV-uninfected adults (left),
but there was a higher proportion of CD8+ effector memory and a lower proportion of CD8+ terminal effector in HIV-infected individuals compared to
HIV-uninfected adults (right). Black horizontal bars represent median and IQRs. Statistical significance was analysed by the ManneWhitney U test. p
value <0.05 was used to determine statistical significance.
Thorax 2011;66:375e382. doi:10.1136/thx.2010.153825 377
Respiratory infection
 group.bmj.com on June 17, 2011 - Published by thorax.bmj.comDownloaded from 
Regulatory T cells (Tregs)
We investigated the hypothesis that in HIV-infected individuals,
persistent immune activation by HIV results in a higher
frequency of regulatory T cells. Blood and BAL Tregs were
deﬁned as CD4+CD25hiFoxP3+ as described in the materials and
methods (ﬁgure 3A). The proportions of Tregs in HIV-infected
individuals were similar in BAL and peripheral blood (median
3.7% vs 3%, p>0.01), but were higher in BAL compared to
peripheral blood in HIV-uninfected adults (median 4.3% vs 1.5%,
p<0.001) (ﬁgure 3B). There was a higher proportion of Tregs in
the peripheral blood of HIV-infected individuals than in the
HIV-uninfected adults (median 3% vs 1.5%, p<0.001). However,
in BAL the proportions were similar between the groups
(median 3.7% vs 4.3%, p>0.01) (ﬁgure 3B). Absolute counts,
however, of Tregs in peripheral blood were similar between HIV-
uninfected adults and HIV-infected individuals (median 11 cells/
ml vs 9 cells/ml, p>0.01) (ﬁgure 3C).
Antigen-specific CD4+ T cells against influenza virus,
S pneumoniae and M tuberculosis in BAL and peripheral blood
To investigate respiratory pathogen antigen-speciﬁc T cell
responses in BAL and peripheral blood, we measured the quality
and magnitude of the CD4+ T cell response to inﬂuenza virus,
S pneumoniae and M tuberculosis antigens using intracellular
cytokine staining. We detected antigen-speciﬁc CD4+ T cells
against inﬂuenza virus, S pneumoniae and M tuberculosis in BAL
and peripheral blood (ﬁgure 4).
Differences between BAL and peripheral blood compartments
There was a higher percentage frequency of antigen-speciﬁc
CD4+ T cells against inﬂuenza virus (median 0.51% vs 0.13%,
p<0.001), S pneumoniae (median 0.59% vs 0.11%, p<0.001) and
M tuberculosis (median 5.53% vs 0.20%, p<0.001) in BAL
compared to peripheral blood (ﬁgure 5AeC). The proportion of
antigen-speciﬁc CD4+ T cells against inﬂuenza virus, S pneumo-
niae and M tuberculosis producing either IFN-g alone, TNF-
a alone or both cytokines were different between BAL and
peripheral blood (ﬁgure 6AeC). Background responses were
subtracted from all the antigen-speciﬁc CD4+ T cell responses.
Differences between HIV-infected and HIV-uninfected adults
The percentage frequency of antigen-speciﬁc CD4+ T cells
against inﬂuenza virus (median 0.15% vs 0.51%, p<0.05) and
M tuberculosis (median 0.5% vs 5.53%, p<0.05) antigens were
lower in HIV-infected individuals compared to HIV-uninfected
adults in BAL (ﬁgure 5A,C). However, this was not the case in
peripheral blood where the percentage frequencies were
comparable (Inﬂuenza virus, median 0.3% vs 0.13%, p>0.05;
M tuberculosis, median 0.12% vs 0.19% p>0.05)(ﬁgure 5A,C). The
percentage frequency of antigen-speciﬁc CD4+ T cells against S
pneumoniae were similar in HIV-infected compared to HIV-
uninfected adults in BAL (median 0.84% vs 0.59%, p>0.05).
However, in peripheral blood the percentage frequency was
higher in HIV-infected compared to HIV-uninfected adults
(median 0.2% vs 0.1%, p¼0.02) (ﬁgure 5B). Background
Figure 3 Higher frequency of
regulatory T cells in BAL compared to
peripheral blood, but altered in HIV-
infected individuals. T lymphocytes
obtained from BAL and peripheral blood
were stained with anti-CD4 Pacific blue,
anti-CD25 FITC and anti-Foxp3 PE
fluorochrome conjugated antibodies.
Regulatory T cells (Tregs) were defined
as CD4+ T cells expressing CD25hi and
FoxP3+. (A) A flow cytometry
representative dot plot showing Tregs in
BAL and peripheral blood from a healthy
control. (B) The data shows a higher
frequency of Tregs in BAL than
peripheral blood in HIV-uninfected
adults. It also shows a higher frequency
of peripheral blood Tregs in HIV-infected
individuals compared to HIV-uninfected
adults. (C) The data shows no difference
in the absolute counts of Tregs in
peripheral blood between HIV-infected
individuals and HIV-uninfected adults.
Black horizontal bars represent median
and IQRs. Statistical significance was
analysed by the ManneWhitney U test
in the HIV-uninfected versus HIV-
infected comparison, and Wilcoxon
Signed rank test in the BAL versus
peripheral blood comparison. p value
<0.05 was used to determine statistical
significance.
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Figure 4 Representative flow cytometry dot flow from an HIV-uninfected adult showing multiple subsets of antigen-specific CD4+ T cells in BAL and
peripheral blood. BAL and peripheral blood lymphocytes were stimulated with antigens and T cell responses were measured by intracellular cytokine
staining. Representative flow cytometry dot plots from an HIV-uninfected adult showing interferon-g (IFN-g) and TNF-alpha (TNF-a) responses in BAL
(top) and peripheral blood (bottom) cells, in an unstimulated negative control and cells stimulated with influenza virus, S. pneumoniae and M
tuberculosis antigens.
Figure 5 Lower frequency of antigen-specific BAL CD4+ T cells in HIV-infected individuals compared to HIV-uninfected adults. BAL and peripheral
blood lymphocytes were stimulated with antigens and the magnitude of the antigen-specific T cell response was measured by intracellular cytokine
staining. The total of all cytokine-secreting CD4+ T cells was used to represent the percentage frequency of antigen-specific cells. (A) The data shows
a higher percentage frequency of influenza virus antigen-specific CD4+ T cells in BAL compared to peripheral blood in HIV-uninfected adults. It also
shows a lower percentage frequency of BAL influenza virus antigen-specific CD4+ T cells in HIV-infected individuals compared to HIV-uninfected
adults. (B) The data shows a higher percentage frequency of S pneumoniae antigen-specific CD4+ T cells in BAL compared to peripheral blood in HIV-
uninfected adults. It also shows a higher percentage frequency of S pneumoniae antigen-specific peripheral blood CD4+ T cells in HIV-infected
individuals compared to HIV-uninfected adults. (C) The data shows a higher percentage frequency of M tuberculosis antigen-specific CD4+ T cells in
BAL compared to peripheral blood in HIV-uninfected adults. It also shows a lower percentage frequency of BAL M tuberculosis antigen-specific CD4+ T
cells in HIV-infected individuals compared to HIV-uninfected adults. Black horizontal bars represent median and IQRs after background responses were
subtracted from all the antigen-specific CD4 T cell responses. Statistical significance was analysed by the ManneWhitney U test in the HIV-uninfected
versus HIV-infected comparison, and Wilcoxon Signed rank test in the BAL versus peripheral blood comparison. p value <0.05 was used to determine
statistical significance.
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responses were subtracted from all the antigen-speciﬁc CD4+ T
cell responses.
Further, in BAL and peripheral blood, there was a lower
proportion of multiple cytokine-producing (polyfunctional)
antigen-speciﬁc CD4+ T cells against inﬂuenza virus (BAL, 59%
vs 27%; Blood, 41% vs 34%) and M tuberculosis (BAL, median
77% vs 41%; Blood, median 57% vs 26%) in HIV-infected
individuals compared to HIV-uninfected adults (ﬁgure 6A,C).
DISCUSSION
The authors have demonstrated compartment differences
between T cell immunity in the bronchoalveolar space and the
periphery. These include a predominant presence of effector
memory Tcells and regulatory CD4+ Tcells in BAL, and a higher
percentage frequency of antigen-speciﬁc CD4+ T cells against
inﬂuenza virus, S pneumoniae andM tuberculosis in BAL compared
to peripheral blood. Our data has also demonstrated that HIV-
infected individuals have impaired pulmonary CD4+ T cell
immunity, which is characterised by lower proportions of total
CD4+ T cells and impaired antigen-speciﬁc BAL CD4+ T cell
response to inﬂuenza virus and M tuberculosis antigens.
Consistent with previous observations,21 we noticed that BAL
CD4+ and CD8+ Tcells were predominantly of effector memory
phenotype irrespective of HIV status, while peripheral blood T
cell phenotypes were distributed among naive, central memory,
effector memory and terminal effector. Effector memory T cells
migrate to the lung following antigen presentation by antigen
presenting cells in the local draining lymph nodes.22 In the lung,
effector memory T cells may be involved in mediating host
defence against pathogens through macrophage activation and
neutrophil recruitment.9 10 Formulation of vaccines which can
induce effector memory T cells in the lung, mimicking the
natural route of exposure, might improve the efﬁcacy of future
vaccines against pulmonary mucosal infections such as pneu-
mococcal pneumonia.
The authors observed a higher proportion of regulatory Tcells
in BAL ﬂuid compared to peripheral blood in HIV-uninfected
adults. Immunity in the lung is well regulated. A high degree of
regulation is necessary because an excessive response may lead to
destructive immunopathology, while a weak response may lead
to prolonged infection. The higher proportion of Tregs in BAL,
compared to peripheral blood in HIV-uninfected adults, may
reﬂect the capacity for highly regulated immunity in the lung.
While beneﬁcial to the host, this sophisticated level of pulmo-
nary immunocompetence poses a challenge to the potential
success of mucosally-administered vaccines against respiratory
pathogens.
In addition to the overall phenotypic differences between BAL
and peripheral blood T cells seen in this study, the authors
observed a higher percentage frequency of antigen-speciﬁc CD4+
Tcells against inﬂuenza virus, S pneumoniae and M tuberculosis in
BAL, when compared to the peripheral blood of HIV-uninfected
adults. The authors investigated a variety of respiratory antigens
in this study and demonstrated that each pathogen has its
unique cytokine secreting proﬁle. The inﬂuenza virus antigen-
speciﬁc CD4+ T cells were likely induced through previous
infection or exposure. The pneumococcal antigen-speciﬁc CD4+
T cells were probably induced through previous exposure
following contact, colonisation in the nasopharynx or disease.
The M tuberculosis antigen-speciﬁc CD4+ T cells may have been
induced by previous BCG vaccination, latent infection or expo-
sure. Despite differences in kinetics of exposure, our data suggest
that antigen-speciﬁc CD4+ T cell responses against common
respiratory pathogens are compartmentalised in the lung, where
they may confer protection at the site of antigen entry. There-
fore, the induction of pulmonary antigen-speciﬁc CD4+ T cells
Figure 6 Lower proportion of polyfunctional antigen-specific CD4+ T cells in BAL and peripheral blood of HIV-infected individuals compared to HIV-
uninfected adults. BAL and peripheral blood lymphocytes were stimulated with antigens and the quality of the antigen-specific T cell response was
measured by intracellular cytokine staining. The proportion of single producers (IFN-g alone or TNF-a alone) and double producers (IFN-g and TNF-a)
in the antigen-specific CD4+ T cell population was defined. (A) The data shows that in both BAL (upper) and peripheral blood (lower), the proportion of
double producers (green) in the influenza virus antigen-specific CD4+ T cell population was lower in HIV-infected individuals (right) than HIV-uninfected
adults (left). It also shows that the proportion of subsets of antigen-specific CD4+ T cells against influenza virus including IFN-g single producers (blue),
TNF-a single producers (red), and IFN-g/TNF-a double producers (green) were different between BAL (upper) and peripheral blood (lower) in HIV-
uninfected adults. (B) The data shows that the proportion of subsets of antigen-specific CD4+ T cells against S pneumoniae (including single producers
and double producers), were different between BAL (upper) and peripheral blood (lower) in HIV-uninfected adults. (C) The data shows that in BAL
(upper) and peripheral blood (lower) the proportion of double producers (green) in the M tuberculosis antigen-specific CD4 T cell population was lower
in HIV-infected individuals (right) than HIV-uninfected adults (left). It also shows that the proportion of subsets of antigen-specific CD4+ T cells against
M tuberculosis (including single producers, and double producers), were different between BAL (upper) and peripheral blood (lower) in HIV-uninfected
adults.
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through vaccination may provide a useful strategy for
preventing respiratory infections in the lung.
In the context of HIV, ﬁrst, the authors observed a higher
proportion of BAL and peripheral blood effector memory CD4+
and CD8+ T cells in HIV-infected individuals than in HIV-
uninfected adults. This may be attributed to the high level of
hyper-activation associated with HIV infection,23 whereby naive
T cells are driven along their differentiation pathway to become
effector memory T cells.
Second, the authors observed a higher proportion of Tregs in
the blood of HIV-infected individuals compared to HIV-unin-
fected adults. This observation is consistent with other studies
on Tregs in peripheral blood during HIV infection.24 Expressing
Tregs as absolute counts, however, showed that there was no
difference between HIV-uninfected adults and HIV-infected
individuals. This suggests that, during HIV infection, non-Tregs
are preferentially depleted compared to Tregs. In contrast, the
authors did not observe a difference in proportion of BAL Tregs
between HIV-infected individuals and HIV-uninfected adults.
However, the proportion of BAL CD8+ T cells was higher in
HIV-infected compared to HIV-uninfected adults, suggesting
that there is either a depletion of CD4+ Tcells or an inﬁltration
of CD8+ T cells. Taking these observations together, there is
likely to be an altered ratio of Tregs to effector CD4+ and CD8+
T cells in BAL. This factor may either tip the balance to over-
regulation of CD4 responses or lack of control of CD8 inﬁltrates
in HIV-infected adults.
Third, consistent with the earlier observation on altered
proportions of pulmonary T cell subsets in HIV-infected indi-
viduals, the percentage frequencies of inﬂuenza virus and
M tuberculosis antigen-speciﬁc BAL CD4+ T cells were lower in
HIV-infected individuals compared to HIV-uninfected adults.
This is in line with a recent observation that there was depletion
of BAL M tuberculosis antigen-speciﬁc CD4+ T cells in HIV-
infected individuals.21 Recent work from other investigators has
shown a preferential depletion of peripheral blood M tuberculosis
antigen-speciﬁc but not cytomegalovirus (CMV) antigen-speciﬁc
CD4+ T cells in HIV-infected adults.25 They concluded that
M tuberculosis antigen-speciﬁc adaptive immunity is particularly
vulnerable to HIV-associated immune damage. This study has
shown that adaptive immunity to other respiratory antigens
such inﬂuenza virus and not only M tuberculosis is also impaired
in HIV-infected individuals. The impaired antigen-speciﬁc BAL
CD4+ T cell response observed in this study might help to
explain the increased susceptibility of HIV-infected individuals
to inﬂuenza virus and M tuberculosis infections.17 26 The
impaired BAL CD4+ Tcell immunity to inﬂuenza virus in HIV-
infected adults may result in increased risk to secondary bacte-
rial infection such as pneumococcal pneumonia. The authors
observation that there were detectable antigen-speciﬁc CD4+ T
cell defects in BAL, but not in peripheral blood, has implications
for clinical practice and for vaccine development. Most available
assays, being based on peripheral blood, do not detect local
responses in the lung and may therefore give misleading results
when used for diagnosis or for estimations of vaccine efﬁcacy.
Lastly, the authors demonstrated that there was a lower
proportion of polyfunctional CD4+ Tcells in BAL and peripheral
blood of HIV-infected individuals compared to HIV-uninfected
adults. This observation is consistent with others that have
showed impaired polyfunctionality in M tuberculosis antigen-
speciﬁc CD4+ T cells in BAL from HIV-infected adults.21
Recently, it has been shown that during HIV infection,
M tuberculosis antigen-speciﬁc Tcells in blood change from poly-
functional CD4+ Tcells to a more predominant monofunctional
CD8+ T cell phenotype.27 The authors speculate that owing to
hyperactivation induced by HIV,23 Tcells are driven towards the
terminal differentiation stages of their life cycle, where there is
loss of the ability to secrete more than one cytokine.28 It has been
reported that polyfunctional Tcells may be functionally superior
to monofunctional T cells and may provide a correlate of
protection against parasitic,29 bacterial30 and viral pathogens.31
This ﬁnding provides supporting evidence to the suggestion that
an impaired repertoire of multifunctionality, as well as lower
absolute numbers of respiratory antigen-speciﬁc CD4+ T cell
immunity, may contribute to the high burden of respiratory
diseases in HIV-infected individuals.
In conclusion, the authors have demonstrated that HIV
infection is associated with impaired pulmonary antigen-speciﬁc
CD4+ T cell immunity against viral and bacterial respiratory
pathogens. These defects in pulmonary immunity may help to
explain the observed increased risk of acute lower respiratory
tract infections in HIV-infected adults at any point during the
fall in their systemic CD4 count. A greater understanding of
antigen-speciﬁc T cell responses that occur in the lungs of HIV-
infected individuals will potentially enable better planning of
clinical care for these individuals e in terms of prophylactic
treatments against common infectious pathogens and the
timing of anti-retroviral medication. In addition, it will also
provide appropriate markers of efﬁcacy in future vaccine trials
for common respiratory pathogens such as S pneumoniae,
M tuberculosis and inﬂuenza virus.
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MRSA colonisation may lead to increased mortality in
patients with cystic fibrosis
The long-term impact of respiratory tract methicillin-resistant Staphylococcus aureus (MRSA)
on cystic ﬁbrosis (CF) outcomes is unclear. This cohort study used longitudinal data from the
US CF registry between 1996 and 2008. The aim of the study was to assess whether
acquisition of MRSA inﬂuenced mortality.
A total of 19 833 MRSA negative patients aged 6e45 years were included in the study. Over
the study period 5759 patients developed positive cultures for MRSA and there were 2537
deaths. The mortality rate was 27.7 deaths (95% CI 25.3 to 30.4) per 1000 patient-years in
patients with MRSA and 18.3 deaths (95% CI 17.5 to 19.1) per 1000 patient-years in those
without MRSA. After adjusting for variables associated with disease severity, the risk of death
in patients positive for MRSA was higher than in patients who never cultured MRSA, with
the greatest risk in patients chronically colonised with MRSA. Interestingly, patients who
cleared MRSA within a year did not have an increased risk of death. No treatment or
eradication data were described in the study.
This study provides convincing evidence that MRSA is an important pathogen in the CF
airway. Questions remain about both the pathogenesis of MRSA infection and the optimal
medical management in chronically infected patients. For now it is essential that strict
infection control is in place to minimise transmission, and that eradication protocols are
followed after a new identiﬁcation.
< Dasenbrook EC, Checkley W, Merlo CA, et al. Association between respiratory tract methicillin-resistant Staphylococcus
aureus and survival in cystic fibrosis. JAMA 2010;303:2386e92.
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